The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer

医学 全身疗法 阶段(地层学) 肺癌 回顾性队列研究 外科 内科学 癌症 全身性疾病 疾病 生物 古生物学 乳腺癌
作者
Pieter J.M. Joosten,Adrianus J. de Langen,Vincent van der Noort,Kim Monkhorst,Houke M. Klomp,Alexander A. F. A. Veenhof,Chris Dickhoff,Egbert F. Smit,Koen J. Hartemink
出处
期刊:Lung Cancer [Elsevier]
卷期号:161: 141-151 被引量:4
标识
DOI:10.1016/j.lungcan.2021.09.019
摘要

Objectives: Patients with advanced stage non-small cell lung cancer (NSCLC) are generally considered incurable.The mainstay of treatment for these patients is systemic therapy.The addition of local treatment, including surgery, remains controversial.Oligoprogression is defined as advanced stage NSCLC with limited progression of disease after a period of prolonged disease stabilisation or after a partial or complete response on systemic therapy.In this retrospective study we evaluated outcome and survival of patients who underwent a resection for oligoprogression after systemic therapy for advanced stage NSCLC.Materials and Methods: Patients with oligoprogression after systemic treatment for advanced NSCLC who were operated in the Antoni van Leeuwenhoek Hospital were included.Patient and treatment characteristics were collected in relation to progression free survival (PFS) and overall survival (OS).Results: Between January 2015 and December 2019, 28 patients underwent surgery for an oligoprogressive lesion (primary tumor lung (n = 12), other metastatic site (n = 16)).Median age at time of resection was 60 years (39-86) and 57% were female.Postoperative complications were observed in 2 patients (7%).Progression of disease after resection of the oligoprogressive site was observed in 17 patients (61%).Median PFS was 7 months since date of resection (95% CI 6.0-25.0)and median OS was not reached.Seven patients (25%) died during follow-up.Age was predictive for OS and clinical T4 stage was predictive for PFS.M1 disease at initial presentation was predictive for better PFS compared to patients who were diagnosed with M0 disease initially.Patients who underwent resection because of oligoprogression of the primary lung tumour had a better PFS, when compared to oligoprogression of another metastastic site.Conclusion: Surgical resection of an oligoprogressive lesion in patients with advanced NSCLC treated with systemic treatment is feasible and might be considered in order to achieve long term survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
俭朴乐珍发布了新的文献求助10
刚刚
刚刚
搜集达人应助秋以南采纳,获得10
1秒前
从容寻云完成签到,获得积分10
2秒前
allucky发布了新的文献求助10
2秒前
苏书白应助畜牧笑笑采纳,获得50
3秒前
4秒前
sujustin333发布了新的文献求助10
5秒前
6秒前
7秒前
念与惜发布了新的文献求助10
7秒前
allucky完成签到,获得积分10
8秒前
8秒前
9秒前
迟jjpp发布了新的文献求助10
9秒前
冲锋的大头菜完成签到,获得积分10
9秒前
花见月开发布了新的文献求助10
10秒前
香蕉觅云应助飞云采纳,获得30
10秒前
科研通AI2S应助BruceCJH采纳,获得30
10秒前
灿烂千阳发布了新的文献求助10
13秒前
TY发布了新的文献求助10
14秒前
昆1231231231完成签到,获得积分10
14秒前
15秒前
Brill完成签到,获得积分10
15秒前
16秒前
桐桐应助naturehome采纳,获得10
17秒前
玛丽发布了新的文献求助20
18秒前
灿烂千阳完成签到,获得积分10
19秒前
昆1231231231发布了新的文献求助10
19秒前
19秒前
20秒前
21秒前
ppboyindream发布了新的文献求助10
21秒前
瑶咕隆咚发布了新的文献求助10
22秒前
strings发布了新的文献求助10
22秒前
22秒前
英姑应助加菲丰丰采纳,获得10
22秒前
zzc关闭了zzc文献求助
22秒前
英俊的铭应助洋芋采纳,获得10
23秒前
24秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3149204
求助须知:如何正确求助?哪些是违规求助? 2800294
关于积分的说明 7839427
捐赠科研通 2457845
什么是DOI,文献DOI怎么找? 1308138
科研通“疑难数据库(出版商)”最低求助积分说明 628436
版权声明 601706